Start Date
February 27, 2018
Primary Completion Date
December 6, 2023
Study Completion Date
December 6, 2023
NANT-008
Paclitaxel: benzenepropanoic acid, β-(benzoylamino)-α-hydroxy-(2aR, 4S, 4aS, 6R, 9S, 11S, 12S, 12aR, 12bS)-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a, 3, 4, 4a, 5, 6, 9, 10, 11, 12, 12a, 12b-dodecahydro-4,11-dihydroxy-4a, 8, 13, 13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca\[3,4\]benz\[1,2-b\]oxet-9-y1ester,(αR,βS)-(9CI)
Fluorouracil Injectable Product
5-fluoro-2,4 (1H,3H)-pyrimidinedione.
Avastin Injectable Product
Recombinant humanized monoclonal IgG1 antibody
Leucovorin Calcium Injection
Calcium N -\[p -\[\[\[(6RS )-2-amino-5-formyl-5,6,7,8-tetrahydro-4-hydroxy-6-pteridinyl\]methyl\]amino\]benzoyl\]-L-glutamate (1:1).
Eloxatin Injectable Product
cis-\[(1 R,2 R)-1,2-cyclohexanediamine-N,N'\] \[oxalato(2-)- O,O'\] platinum.
Chan Soon-Shiong Institutes for Medicine, El Segundo
Lead Sponsor
NantPharma, LLC
INDUSTRY